Acetylsalicylic Acid

Diabetes Mellitus, Type 2

Galala UniversityPhase 4 / ApprovedActive

BB

69/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 61/ 100
Competitive Position: 81/ 100

Competitive context

50 Active assets in the Diabetes Mellitus, Type 2 cohort.

Asset / Sponsor	Phase	Rating
Semaglutide Shanghai Jiao Tong University School of Medicine	Phase 4	BBB
Exenatide Vivani Medical, Inc	Phase 4	BBB
Dapagliflozin Bhavya Bhavya, MD	Phase 4	BBB
Metformin Myopharm Limited	Phase 4	BBB
Letrozole ARKAY Therapeutics	Phase 4	BBB

View all 50 →

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant

A

Indicative ·

83 / 100

coronary artery disorderDormant

BBB

Indicative ·

79 / 100

cardiovascular disorderDormant

BBB

Indicative ·

78 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.